PET-CT for Cancer Staging: — How It Shows How Far Cancer Has Spread

Staging determines the starting point for almost every major treatment decision: which treatment is used, whether the aim is to remove all disease or control it over time, how many cycles are needed, and whether surgery or radiation is part of the plan. A cancer confined to one area is treated differently from one that has reached distant organs or lymph nodes — even when the cancer type is the same. This is why your doctor needs to know the extent of disease before starting, not during.

There is no single figure that applies across all cancers, and any number you see quoted is specific to a cancer type and patient population. What ESMO and NCCN guidance consistently reflects is that for lymphoma, lung cancer, head and neck cancer, and several other types, PET-CT changes the clinical stage — and therefore the management plan — in a meaningful proportion of patients compared with CT alone. This is precisely why it is recommended for staging in those cancers. Your oncologist can tell you whether this applies to your specific diagnosis.

Not necessarily, and this is one of the most important misunderstandings to address. Stage is a description of where the cancer is, not a verdict on what will happen. Some cancers respond very well to treatment even at an advanced stage. Some early-stage cancers are biologically aggressive. Stage is one input into a treatment plan, alongside the cancer type, its biological markers, your general fitness, and your own priorities. Your oncologist considers all of these together, not stage alone.

CION coordinates PET-CT scans through partner imaging centres in Hyderabad. Your care team will arrange the referral and provide the preparation instructions. The scan report is interpreted by a nuclear medicine physician or radiologist at the imaging centre, then reviewed by your oncologist at CION, who will explain what the findings mean for your treatment plan.

The scan itself takes one to two hours, most of which is waiting after the tracer is injected while it distributes through your body. The report is usually available within one to three working days, depending on the imaging centre. Your oncologist will then discuss the findings with you — at a scheduled appointment, or sooner if the findings require an urgent plan change. Ask your care team when to expect the report and how you will be contacted.

For some cancer types and some clinical situations, staging with CT and other investigations is an acceptable alternative — particularly where PET-CT would not be expected to change the management plan. Your oncologist will tell you whether it is essential for your staging or recommended but not mandatory. If access or cost is a concern, raise it directly with your care team rather than going without investigation. There may be options through government schemes or a staged approach to investigations.